UA114123C2 - Водна композиція диклофенаку - Google Patents
Водна композиція диклофенакуInfo
- Publication number
- UA114123C2 UA114123C2 UAA201506371A UAA201506371A UA114123C2 UA 114123 C2 UA114123 C2 UA 114123C2 UA A201506371 A UAA201506371 A UA A201506371A UA A201506371 A UAA201506371 A UA A201506371A UA 114123 C2 UA114123 C2 UA 114123C2
- Authority
- UA
- Ukraine
- Prior art keywords
- diclofenac
- composition
- aqua composition
- aqua
- vol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Винахід стосується водної композиції для ін’єкцій, що містить 25-200 мг/мл диклофенаку та його солі у розчині 5-50 % (мас./об.) простого моноетилового ефіру діетиленгліколю та води як головного розчинника, а також способу одержання зазначеної композиції.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3704MU2012 | 2012-12-28 | ||
| PCT/IN2013/000805 WO2014102824A1 (en) | 2012-12-28 | 2013-12-27 | Diclofenac composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA114123C2 true UA114123C2 (xx) | 2017-04-25 |
Family
ID=54198802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201506371A UA114123C2 (xx) | 2012-12-28 | 2013-12-27 | Водна композиція диклофенаку |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20140187635A1 (uk) |
| EP (1) | EP2938325B8 (uk) |
| JP (1) | JP6117939B2 (uk) |
| KR (1) | KR101730284B1 (uk) |
| CN (1) | CN104968331A (uk) |
| AP (1) | AP2015008534A0 (uk) |
| AU (1) | AU2013368849B2 (uk) |
| BR (1) | BR112015015699B1 (uk) |
| CL (1) | CL2015001869A1 (uk) |
| EA (1) | EA035079B1 (uk) |
| ES (1) | ES2721400T3 (uk) |
| HK (1) | HK1211858A1 (uk) |
| HU (1) | HUE045030T2 (uk) |
| IL (1) | IL239395A0 (uk) |
| MA (1) | MA38292A1 (uk) |
| MX (1) | MX365375B (uk) |
| MY (1) | MY184886A (uk) |
| PE (1) | PE20151208A1 (uk) |
| PH (1) | PH12015501479A1 (uk) |
| SG (1) | SG11201504577UA (uk) |
| SI (1) | SI2938325T1 (uk) |
| TR (1) | TR201905806T4 (uk) |
| UA (1) | UA114123C2 (uk) |
| WO (1) | WO2014102824A1 (uk) |
| ZA (1) | ZA201504258B (uk) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101524473B1 (ko) * | 2014-12-22 | 2015-06-02 | 주식회사 한국팜비오 | 주사제 조성물 |
| WO2016170401A1 (en) * | 2015-04-20 | 2016-10-27 | Umedica Laboratories Pvt. Ltd | Novel injectable composition of diclofenac sodium |
| US11110073B2 (en) | 2017-03-24 | 2021-09-07 | Cadila Healthcare Limited | Storage stable aqueous injectable solution comprising diclofenac |
| GB201720992D0 (en) * | 2017-12-15 | 2018-01-31 | Hooper Mark | A medical use |
| GR1009729B (el) * | 2018-08-02 | 2020-05-15 | Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια | Σταθερος ενεσιμος συνδυασμος |
| BR112021006508A2 (pt) * | 2018-11-16 | 2021-07-06 | Seikagaku Kogyo Co Ltd | composição aquosa, kit, métodos para tratar uma doença articular humana, para produzir uma composição farmacêutica e para suprimir a geração de diclofenaco lactâmico, e, composição farmacêutica. |
| WO2021048748A1 (en) | 2019-09-09 | 2021-03-18 | Ftf Pharma Private Limited | Pharmaceutical formulations comprising diclofenac |
| US11707443B2 (en) | 2019-09-26 | 2023-07-25 | Rk Pharma Inc. | Storage stable aqueous parenteral solutions comprising diclofenac |
| KR20220143037A (ko) * | 2020-02-18 | 2022-10-24 | 노보 노르디스크 에이/에스 | Glp-1 조성물 및 이의 용도 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3324193A1 (de) | 1983-07-05 | 1985-01-17 | Troponwerke Gmbh & Co Kg | Depot-antiphlogistika |
| DE3446873A1 (de) | 1984-12-21 | 1986-07-10 | Merckle Gmbh | Fluessige diclofenac-zubereitungen |
| US5283067A (en) * | 1987-01-30 | 1994-02-01 | Ciba-Geigy Corporation | Parenteral suspensions |
| CA2112378A1 (en) * | 1991-07-04 | 1993-01-21 | Masakazu Kanazawa | Analgesic preparation |
| US5389681A (en) | 1992-10-22 | 1995-02-14 | Ciba-Geigy Corporation | Parenteral solutions for diclofenac salts |
| ZA949182B (en) | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
| JP4542743B2 (ja) * | 2002-12-26 | 2010-09-15 | Ｋｄｌ株式会社 | ピリドン誘導体の溶液状医薬組成物 |
| EP1605900A4 (en) * | 2003-03-26 | 2007-10-17 | Becton Dickinson Co | USE OF BENZYL ALCOHOL AND OTHER PHENOLIC PRESERVATIVE SUBSTANCES TO REDUCE PAIN IN INTRADERMAL INJECTION |
| US20050137164A1 (en) * | 2003-09-22 | 2005-06-23 | Moshe Arkin | Diclofenac compositions for the treatment of skin disorders |
| ES2336034T3 (es) | 2004-03-10 | 2010-04-07 | Shimoda Biotech (Pty) Ltd | Composiciones de diclofenaco inyectables estables. |
| US20050214230A1 (en) * | 2004-03-23 | 2005-09-29 | J. B. Chemicals & Pharmaceuticals Ltd. | Novel stomatological gel |
| CA2596031C (en) * | 2005-02-01 | 2013-02-19 | Troikaa Pharmaceuticals Ltd | Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
| CN101217939A (zh) * | 2005-05-27 | 2008-07-09 | 灵药生物技术有限公司 | 可注射组合物及制备这类组合物的方法 |
| JP2012510439A (ja) | 2008-11-28 | 2012-05-10 | アドヴァンス ホールディングス リミテッド | ジクロフェナクおよびヒドロキシ脂肪酸ポリオキシアルキレンエステルを含む医薬製剤 |
-
2013
- 2013-12-24 US US14/140,109 patent/US20140187635A1/en not_active Abandoned
- 2013-12-27 JP JP2015550212A patent/JP6117939B2/ja active Active
- 2013-12-27 MX MX2015008369A patent/MX365375B/es active IP Right Grant
- 2013-12-27 HU HUE13830158A patent/HUE045030T2/hu unknown
- 2013-12-27 UA UAA201506371A patent/UA114123C2/uk unknown
- 2013-12-27 TR TR2019/05806T patent/TR201905806T4/tr unknown
- 2013-12-27 EA EA201591230A patent/EA035079B1/ru not_active IP Right Cessation
- 2013-12-27 EP EP13830158.5A patent/EP2938325B8/en active Active
- 2013-12-27 MA MA38292A patent/MA38292A1/fr unknown
- 2013-12-27 AU AU2013368849A patent/AU2013368849B2/en active Active
- 2013-12-27 PE PE2015001194A patent/PE20151208A1/es not_active Application Discontinuation
- 2013-12-27 MY MYPI2015001527A patent/MY184886A/en unknown
- 2013-12-27 SG SG11201504577UA patent/SG11201504577UA/en unknown
- 2013-12-27 WO PCT/IN2013/000805 patent/WO2014102824A1/en active Application Filing
- 2013-12-27 SI SI201331424T patent/SI2938325T1/sl unknown
- 2013-12-27 BR BR112015015699-1A patent/BR112015015699B1/pt active IP Right Grant
- 2013-12-27 CN CN201380068194.2A patent/CN104968331A/zh active Pending
- 2013-12-27 ES ES13830158T patent/ES2721400T3/es active Active
- 2013-12-27 KR KR1020157017781A patent/KR101730284B1/ko active IP Right Grant
- 2013-12-27 AP AP2015008534A patent/AP2015008534A0/xx unknown
-
2015
- 2015-06-11 ZA ZA2015/04258A patent/ZA201504258B/en unknown
- 2015-06-14 IL IL239395A patent/IL239395A0/en unknown
- 2015-06-26 CL CL2015001869A patent/CL2015001869A1/es unknown
- 2015-06-26 PH PH12015501479A patent/PH12015501479A1/en unknown
- 2015-12-30 HK HK15112837.5A patent/HK1211858A1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA114123C2 (xx) | Водна композиція диклофенаку | |
| CY1121497T1 (el) | Συριγγα | |
| AR122552A2 (es) | Composición acuosa de inmunoglobulina estable durante el almacenamiento y método para estabilizar una composición de inmunoglobulina | |
| BR112013019026A2 (pt) | formulações farmacêuticas incluindo um composto amina | |
| ECSP13012715A (es) | Método para producir preparados farmacéuticos con contenido de ibp | |
| CR20140275A (es) | Triazolopiridinas sustituidas | |
| CU20140110A7 (es) | Compuestos heterocíclicos como inhibidores de mek | |
| EA201590807A1 (ru) | Стабильные бесконсервантные мидриатические и противовоспалительные растворы для инъекций | |
| CR20150045A (es) | Inhibidores de hepatitis c | |
| EA201791717A1 (ru) | Стабильные водные составы адалимумаба | |
| EA201591748A1 (ru) | Модуляторы p2x7 | |
| CR20150509A (es) | Derivados de naftiridina utiles como antagonistas de la alfa-v-beta-6 integrina | |
| ECSP13013074A (es) | Nuevos derivados de piridina | |
| CR20150250A (es) | Nuevos derivados de piridina | |
| UA115773C2 (uk) | Пірольні сполуки, спосіб їх одержання та фармацевтична композиція, що їх містить (варіанти) | |
| BR112014003566B8 (pt) | composição líquida, processo para a preparação da composição líquida, e, uso de um líquido iônico | |
| EA201691216A1 (ru) | Композиции линаклотида с замедленным высвобождением | |
| EA201500426A1 (ru) | Производные пирролотриазинона в качестве ингибиторов pi3k | |
| EA201490596A1 (ru) | Новые производные дигидрохинолин-2-она | |
| CO6571868A2 (es) | Procedimiento para la formacion de complejos de ciclodextrina para formular inhibidores del proteasoma peptidico | |
| EA201590887A1 (ru) | Композиция | |
| CR20150663A (es) | Derivados de diazacarbazol como ligandos de tau para pet | |
| CR20150204A (es) | Nuevos derivados de piridina | |
| UY32153A (es) | Inhibidores de piridomidinona de pi13ka(alfa) y mtor | |
| BR112015008912A2 (pt) | composições solidificáveis compreendendo volastonita e pedra-pomes e métodos de uso |